Definitions. Prevalence. Chronic Insomnia DSM-5 INSOMNIA. Insomnia Is a Distinct Disorder That Should Be Treated ~10% 3 nights/wk 3 months
|
|
- Jemimah Small
- 5 years ago
- Views:
Transcription
1
2 Chronic Definitions Alon Y. Avidan, M.D., M.P.H UCLA Sleep Disorders Center Is a Distinct Disorder That Should Be Treated NIH (1983) 1 NIH (2005) 2 is a symptom, is a disorder not a disorder DSM-5 INSOMNIA Definition is secondary to a primary disorder is a disorder that typically is comorbid with other disorders 3 nights/wk 3 months Treatment Other Important to treat the primary disorder; insomnia may or may not receive attention Hypnotics should generally be used in the lowest doses and for the shortest period of time Chronic insomnia occurs in the context of medical and psychiatric disorders Treat insomnia as well as other disorders; improvements in insomnia may result in improvements in other disorders Chronic insomnia exists and merits treatment itself is associated with significant impairment in function and quality of life Initiation Trouble falling asleep Maintaining Frequent awakening or trouble returning to sleep after awakening Waking early Waking earlier than desired 1. National Institutes of Health. Drugs and : The Use of Medications to Promote Sleep. NIH Consensus Statement. 1983;4:1-19; 2. National Institutes of Health. State-of-the-Science Conference Statement. Manifestations and Management of Chronic in Adults. 2005:1-18. APA Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition: DSM-5 Approximately 25 Million adults have chronic insomnia 1 Prevalence Approximately 75 Million adults have occasional insomnia 1 $109 Billion Total costs associated with insomnia 2 ~23.5 MM have symptoms consistent with the diagnosis of insomnia 1,3 ~10% of the US population 1,3
3 Prevalence of by Age Group Percent Evolution Age Group Mellinger GD et al. Arch Gen Psychiatry. 1985;42: Longitudinal Patterns of Transient Short Term Chronic Few Days Few days-month >1 month Exam Traumatic event Depression Clinical Symposia 56(1), 2006 Slide courtesy, Tom Roth Neuroimaging Evidence for Hyperarousal in is associated with greater brain metabolism. The inability to fall asleep may be related to failure of arousal mechanisms to decline in activity from waking to sleep states. Impact of Co-morbidity on Prevalence in Adults 50. CVD Arthritis Obesity OAD Other Disease 37.5 During sleep, there was a smaller decline observed in relative metabolism in brainstem, hypothalamic/basal forebrain, and limbic networks in insomnia patients vs. healthy subjects Percent With Without Klink, et al. Arch Intern Med. 1992;152:
4 Causes of Breathing Substances related 5% 5% Other 10% According to Timing at Night Circadian rhythm ( DSPS / shift ) 10% Periodic limb movement 10% Primary / psychophy siologic 20% Psychiatr ic 40% Sleep Initiation RLS Anxiety Drugs Circadian Rhythm Disorders Sleep Maintenance OSA Nocturia Poor sleep environment Terminal Early AM Awakening Depression Circadian Rhythm Disorders Ohayon MM. Sleep Med Rev. 2002;6: Persistence of in Older Adults at 2 Years DFA 36.7 SCD 28.7 EMA DaSom DFA SCD EMA 47.3 DaSom * Persistence of daytime somnolence was significantly associated with mortality (p=0.049); n=1050 DFA = difficulty falling asleep SCD = sleep continuity disturbance EMA = early morning awakening; DaSom = uncontrollable daytime somnolence. Ganguli M et al. J Am Geriatr Soc. 1996;44: Treatment Goals for Fears regarding Hypnotic side effects often contribute to under treatment of insomnia Restore and improve sleep quality and duration Prevent progression from transient, short-term insomnia to chronic insomnia Reduce contribution of, and impact on, comorbid conditions RISKS/ FEARS Fears of addiction, abuse Package label restrictions BENEFITS Efficacy of medications 1. Nadolski N. Plast Surg Nurs. 2005;25(4): Roth T, Culpepper L. Clin Symp. 2008;58(1):3-32.
5 Approach to the Management of Current Approaches for Treatment Diagnosis 1,2 Education, including good sleep practices 1,2 Nonpharmacologic and/or pharmacologic therapy 1,2 Referral to sleep specialist (in cases of treatment failure) 1 1. Kupfer DJ, Reynolds CF III. N Engl J Med. 1997;336: [Evidence Level C]; 2. Consensus Conference. Drugs and insomnia. JAMA. 1984;251: [Evidence Level C] 37 Cognitive & Behavioral Therapy This technique Sleep restriction Stimulus control Relaxation Techniques Targets these symptoms Excessive time spent in bed; fragmented sleep Associating bed with wakefulness High physiologic, cognitive, or emotional arousal Do s: Sleep Hygiene 101 Enhance sleep environment: dark, quiet, cool temper ature Increase exposure to bright light during the day Practice relaxing routine Reduce time in bed; regular sleep/wake cycle Incorporate regular exercise in the morning and/or afternoon Cognitive Misconceptions about sleep and insomnia Don ts: Sleep hygiene education Behaviors that undermine good quality sleep 1. Spielman AJ et al. Psychiatr Clin North Am. 1987;10: ; 10: Walsh JK et al. NIH Publication No Morin CM. Principles and Practice of Sleep Medicine. 2005: Ringdahl EN et al. J Am Board Fam Pract. 2004;17: watch the clock Use stimulants (e.g, caffeine, nicotine, particularly near bedtime) Consume a heavy meals or drink alcohol within 3 hours of bed Use bright light during the nigh, avoid TV/computers e-gadgets. AASM Practice Parameters: Standards Psychological and behavioral interventions are effective and recommended in the treatment of: Chronic primary insomnia Secondary insomnia in older adults among chronic hypnotic users AASM Practice Parameters: Standards AASM Guidelines 1. Other prescription drugs (e.g., gabapentin, tiagabine, quetiapine, olanzapine) should be avoided due to insufficient evidence for efficacy 2. Over the counter agents (e.g., antihistamines, valerian, melatonin) not recomme nded for long term use due to limited efficacy data. Agents NOT Recommended Alcohol Chloral hydrate Barbiturates Non barbiturate non benzodiazepines such as meprobamate Morgenthaler et al., Sleep 2006;29: Schutte Rodin et al. J Clin Sleep Med 2008; 4:
6 What Do People Take to Try to Improve Their Sleep? What Do People Take to Try to Improve Their Sleep? Alcohol 1,2,3 Herbals 3,4 Dietary supplements 1,4 Homeopathic preparations 4 Melatonin 1,3,4 OTC sleep aids 2 Sedating antidepressants 1 Sedative-hypnotics 1,5 Melatonin receptor agonist Hypocretin Receptor Antagonist 1. Neubauer DN. Clinical Cornerstone. 2003;5: Ancoli-Israel S, Roth T. Sleep. 1999;22(suppl 2):S347-S Wagner J et al. Neuro 4. Larzelere MM, Wiseman P.Prim Care Clin Office Pract. 2002;29: Mitler MM. Sleep. 2000;23(suppl 1):S39-S47. Drugs Most Commonly Used for 1 in Verispan PDDA; desired action of hypnotic, promote sleep or sedate night * Projected from 11 month s data 2007 Occurrences (millions) Rank Drug * 1 zolpidem trazodone eszopiclone quetiapine ramelteon mirtazepine temazepam amitriptyline lorazepam clonazepam alprazolam cyclobenzaprine clonidine tizanidine zaleplon carisoprodol Characteristics of the Ideal Hypnotic No memory deficits No respiratory depression No interaction with ethanol No tolerance No physical dependence Rapid absorption Ideal Hypnotic No rebound insomnia No residual effects Address underlying pathophysiology Rapid sleep induction Minimal adverse effect on sleep physiology Optimal duration of action No formation of active metabolites Adapted from Mendelson et al. Sleep Med Rev 2004;8: ASLEEP Ideal insomnia medicine ASLEEP Untreated insomnia AWAKE Take medicine AWAKE Time to wake up Hypnotic Use
7 Drug classes Histamine Receptor Antagonist BZA Receptor Agonists Melatonin Receptor Agonist Hypocretin Receptor Antagonist Agent Initiates Sleep Maintains Sleep Sleep with limited opportunity Required Inactivity (hr) Dose (mg) Eszopiclone 8+ 1,2,3 Zaleplon 4 5,10 Zolpidem 7-8 5,10 Extended release , 12.5 Doxepin Zolpidem Eszopiclone Zaleplon Triazolam Ramelteon Suvorexant Intermezzo (Sublingual) Zolpimist (oral spray) (4 hrs) , , 10 Elduar (Sublingual) 4 5, 10 Silenor 7-8 3, 6 Ramelteon - 8 Suvorexant 7 5, 10, 15, 20 BZRA Hypnotics: Possible Adverse Effects Guideline Consensus Recommendations 2008 AASM Chronic Clinical Guideline Consensus Recommendations Hypnotic treatment should be combined with CBTi when possible. OTC antihistamine as well as herbal and nutritional substances are not recommended in the Tx of chronic insomnia due to the relative lack of efficacy and safety data. Older approved drugs for insomnia including barbiturates, barbiturate-type drugs and chloral hydrate are not recommended for the Tx of insomnia AASM Chronic Clinical Guideline Consensus Recommendations The choice of a specific pharmacologic agent should be directed by: Patient preference & expectation Treatment goals Symptom pattern Cost Comorbid conditions Past treatment response Contraindications Concurrent medication interactions Side effects
8 2008 AASM Chronic Clinical Guideline Consensus Recommendations Effect size Efforts should be made to employ the lowest effective maintenance dosage of medication and to taper medication when conditions allow. Chronic hypnotic medication may be indicated for long-term use in those with severe or refractory insomnia or chronic comorbid illness Long-term use may be nightly, intermittent, or as needed in an on demand pattern. Cognitive therapy CBT-I Z-drugs 0.3 Hypnotics BMJ 2012;345:e8343 The Sleepless Patient: Summary is an extremely common problem Assessment requires careful inventory of potential confounders CBTi is an ideal ideal option Numerous medications are available: Risk analysis: evaluate cost benefit Rx has variable benefit profiles therapy needs to be tailored to meet patient s expectations. Comorbidity Hypnotic Outcome Rheumatoid Arthritis Menopausal Eszopiclone Eszopiclone Improved pain decreased awaking due to hot flashes Fibromyalgia Zolpidem sleep and energy Major Depression Eszopiclone, BZA Improve MDD along with sleep GAD Eszopiclone Improved Hamilton Anxiety Scale (HAMA) Post-Alcohol Discontinuation Trazodone Improves sleep time PTSD Eszopiclone (Prazosin) Improved Sleep & daytime PTSD Sx. References: 1Nolen et al. J Affect Disord Jul;28(3):179-88; 2Londborg PD et al. J Affect Disord Dec;61(1-2):73-9; 3Fava M et al. Biol Psychiatry Jun 1;59(11): ; 4Krystal AD. J Clin Sleep Med Feb 15;3(1):63-72; 5Pollack M et al. Arch Gen Psychiatry May;65(5):551-62; 6Le Bon O et al. J Clin Psychopharmacol Aug;23(4): Fava et al., J Clin Psychopharm.2009 Jun;29(3):222-30; 8Fava et al.j Clin Psych 2011.,9Germain et al, J Psychosom Res. 72(2):89-96:2012; 10Taylor et al., Biol Psych. 2008;63(6): Raskind et al., Biol Psych. 2008;61(8):928-34; 11Raskind et al., Am J Psych. 2003;160(2): Pollack et al., J Clin Psych. 2011;72(7): Limited evidence shows no benefit compared with placebo. The FDA does not regulate valerian, and thus different preparations vary in valerian content. Safety data are minimal, but there have been case reports of hepatotoxicity in persons taking herbal products containing valerian. Other herbal remedies have also been promoted, but efficacy evidence is lacking. Because melatonin is not regulated by the FDA, preparations containing it vary in strength, making comparisons across studies difficult. Although melatonin appears to be effective for the treatment of circadian rhythm disorders (e.g., jet-lag), little evidence exists for efficacy in the treatment of insomnia or its appropriate dosage. In short-term use, melatonin is thought to be safe, but there is no information about the safety of long-term use.
9 Diphenhydramine* Use As a Sedative- Hypnotic in Older Adults (H1 receptor antagonists i.e diphenhydramine) are the most commonly used OTC treatments for chronic insomnia, but there is no systematic evidence for efficacy and there are significant concerns about risks of these medications. Adverse effects include residual daytime sedation, diminished cognitive function, and delirium, the latter being of particular concern in the elderly. Other adverse effects include dry mouth, blurred vision, urinary retention, constipation, and risk of increased intraocular pressure in individuals with narrow angle glaucoma. % Use Over 10 Years OTC Diphenhydramine Prescription Sedative-Hypnotics (primarily benzodiazepines) *Diphenhydramine-containing products include: generic dyphenhydramine, Benadryl, Benylin, Nervine, Aid-To-Sleep, Nytol, Robitussin PM, Tylenol PM, Motrin PM, acetaminophen PM, Excedrin PM, Legatrin PM. 1. Basu R et al. Am J Geriatr Psychiatry. 2003;11: Rickels K et al. J Clin Pharmacol. 1983;23: Kudo Y and Kurihara M. J Clin Pharmacol. 1990;30: Winkelman J et al. Ann Clin Psychiatry. 2005;17: Richardson G et al. J Clin Pharmacol. 2002:22: ) 82 Adverse Events Associated with Trazodone All antidepressants have potentially significant adverse effects, raising concerns about the risk benefit ratio. There is a need to establish doseresponse relationships for all of these agents and communicate them to prescribers. Adverse events raise concerns, especially in older adults: 1 Dizziness 1 Oversedation 1,2 Priapism 3,4 Atrial and ventricular arrhythmias 3 Alpha-adrenergic blockade, including orthostatic hypotension 2 potential for falls 1. Mendelson WB. J Clin Psychiatry. 2005;66: Lippmann S et al. South Med J. 2001;94: Mendelson WB et al. Sleep Med Rev. 2004;8: Winkelman J and Pies R. Ann Clin Psychiatry. 2005;17: A number of other sedating medications have been used in the treatment of insomnia. These include barbiturates (e.g., phenobarbital) and antipsychotics (e.g., quetiapine and olanzepine). Studies demonstrating the usefulness of these medications for either short- or long-term management of insomnia are lacking. Furthermore, all of these agents have significant risks. Thus, their use in the treatment of chronic insomnia cannot be recommended.
DSM-5 INSOMNIA. Maintaining. Maintaining Sleep. Difficulty Falling Asleep: Difficulty. Early AM awakenings: (> 30 minutes before desired wake time)
DSM-5 INSOMNIA 3 nights/wk 3 months Difficulty Falling Asleep: > 30 minutes Difficulty Maintaining Sleep Next Day Consequences Early AM awakenings: (> 30 minutes before desired wake time) Initiation Trouble
More information14. Percent Mellinger GD et al. Arch Gen Psychiatry. 1985;42: ICSD III
4:45 5:45 pm Management of Insomnia and Other Disorders Presenter Disclosure Information The following relationships exist related to this presentation: Alon Y. Avidan, MD, MPH, FAAN, FAASM: Speakers Bureau
More informationLearning Objectives. Management of Insomnia. Impact of Chronic Insomnia. Insomnia: Definitions. Measurement of Goals. Goals of Therapy 9/29/2017
Learning Objectives Characterize insomnia and its negative effects Management of Insomnia Discuss the goals of treatment Summarize guidelines of management of insomnia including non-pharmacologic and pharmacologic
More information14. Percent
4:30 5:45 pm Management of Insomnia and Other Disorders Presenter Disclosure Information The following relationships exist related to this presentation: Alon Y. Avidan, MD, MPH, FAAN, FAASM: Speakers Bureau
More informationInsomnia: Updates in Medical Management. Michael Newnam M.D.
Insomnia: Updates in Medical Management Michael Newnam M.D. Sleep Neurobiology Delicate balance of excitatory and inhibitory neurotransmitters that control the switch between wakefulness and sleep Circadian
More informationSleep Disorders and Insomnia
7:45 8:45 am Management of Insomnia and Other Disorders SPEAKER Alon Y. Avidan, MD, MPH, FAAN, FAASM Presenter Disclosure Information The following relationships exist related to this presentation: Alon
More informationInsomnia Agents (Sherwood Employer Group)
Insomnia Agents (Sherwood Employer Group) BCBSKS will review Prior Authorization requests Prior Authorization Form: https://www.bcbsks.com/customerservice/forms/pdf/priorauth-6058ks-st-ippi.pdf Link to
More informationInsomnia % of adults suffer from chronic and severe insomnia (Complaints of insomnia with daytime consequences)
10-15% of adults suffer from chronic and severe insomnia (Complaints of insomnia with daytime consequences) 30 40% of adults complain of insomnia symptoms only 95% experience insomnia at some time in their
More informationTRAZODONE IN INSOMNIA COMORBID WITH DEPRESSION: AN AWAKENING LACK OF STRONG EVIDENCE
TRAZODONE IN INSOMNIA COMORBID WITH DEPRESSION: AN AWAKENING LACK OF STRONG EVIDENCE Gordon Ang, PharmD Central Texas Veterans Health Care System 1/5/2018 1 Abbreviations Abbreviation GERD MDD PTSD PSQI
More informationPharmacological Help for a Good Night s s Sleep. Thomas Owens, MD
Pharmacological Help for a Good Night s s Sleep Thomas Owens, MD Objectives 1. Define insomnia and characterize the symptoms and array of causes. 2. Describe traditional and new pharmacologic approaches
More informationINSOMNIA IN THE GERIATRIC POPULATION. Shannon Bush, MS4
INSOMNIA IN THE GERIATRIC POPULATION Shannon Bush, MS4 CHANGES IN SLEEP ARCHITECTURE 2 Reduction in slow wave sleep (stage 3 and 4) Increase in lighter stages of sleep (stage 1 and 2) Decrease in REM sleep
More informationCBT for Insomnia: Past, Present, and Future Directions
CBT for Insomnia: Past, Present, and Future Directions J. Todd Arnedt, Ph.D. Associate Professor of Psychiatry and Neurology Director, Behavioral Sleep Medicine Program Acting Director, Sleep and Circadian
More informationInsomnia treatment in primary care
Insomnia treatment in primary care Daniel J. Buysse, MD UPMC Professor of Sleep Medicine Professor of Psychiatry and Clinical and Translational Science University of Pittsburgh School of Medicine buyssedj@upmc.edu
More informationInsomnia Treatment in Brief
Insomnia Treatment in Brief Project ECHO May 7, 2015 Jonathan Emens, M.D. Associate Professor, Departments of Psychiatry and Internal Medicine Oregon Health & Science University Staff Physician and Sleep
More informationAddressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling
Addressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling Educational Objectives: At the completion of this knowledge-based activity, participants will be able to:
More informationCPT David Shaha, MC US Army
CPT David Shaha, MC US Army None Thoughts and comments are my own and do not represent the official policy of the Department of the Army, Department of Defense, or United States Government. Clinical Case
More informationDr Alex Bartle. Sleep Well Clinic
Dr Alex Bartle Sleep Well Clinic Overview of Sleep Disorders Sleep: Why bother. Effect of Poor Quality or reduced Quantity of Sleep Common Sleep Disorders Management of Insomnia Medication vs CBTi Conclusion
More informationWHEN SHOULD I USE SLEEP AIDS IN MY PATIENTS WITH SLEEP DISORDERS... (AND WHEN SHOULD I NOT?)
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences WHEN SHOULD I USE SLEEP AIDS IN MY PATIENTS WITH SLEEP DISORDERS... (AND WHEN SHOULD I NOT?) CATHERINE MCCALL, MD
More informationTreating sleep disorders
Treating sleep disorders Sue Wilson Centre for Neuropsychopharmacology Imperial College London sue.wilson@imperial.ac.uk Suggested algorithm for treatment of insomnia Diagnosis of insomnia Associated with
More informationInsomnia. Learning Objectives. Disclosure 6/7/11. Research funding: NIH, Respironics, Embla Consulting: Elsevier
Insomnia Teofilo Lee-Chiong MD Professor of Medicine National Jewish Health University of Colorado Denver School of Medicine Learning Objectives Learn about the causes of transient and chronic Learn how
More informationManaging Insomnia Disorder A Review of the Research for Adults
Managing Insomnia Disorder A Review of the Research for Adults e Is This Information Right for Me? This information is right for you if: Your health care professional said you have insomnia disorder (said
More informationQuestion #1. Disclosures. CAPA 2015 Annual Conference. All of the following occur as we get older EXCEPT: Evaluating Patients with Insomnia
Evaluating Patients with Roger D. Seheult, M.D. Pulmonary Critical Care Physician - Beaver Medical Group, Redlands California Assistant Clinical Professor of Medicine - Loma Linda University School of
More informationThe Use of Sleep Aids in Our Society Today
The Use of Sleep Aids in Our Society Today Kathryn Hansen, BS, CPC, CPMA, REEGT Integration Consultants, LLC Sleep Education Partners Executive Director Kentucky Sleep Society Executive Director Society
More informationAddressing Pharmacologic Issues in. DSM-5 Sleep-Wake. Insomnia. Disorders. DSM-5 Insomnia Disorder. Insomnia. Disorder
Addressing Pharmacologic Issues in David N. Neubauer, MD Associate Professor of Psychiatry and Behavioral Sciences Johns Hopkins School of Medicine Baltimore, Maryland Restless Legs Syndrome Substance/
More informationAGING CHANGES IN SLEEP
OBJECTIVES: Understand the common age-related changes in sleep Discuss the evaluation of the older person with sleep complaints Identify sleep apnea, PLMS, RLS, and REM sleep disorders and their treatments
More informationInsomnia treatment. Sleep hygiene education sleep hygiene teaches good sleeping habits. This includes:
Insomnia treatment INSOMNIA OVERVIEW insomnia is defined as difficulty falling asleep, difficulty staying asleep, or waking up early in the morning and not being able to return to sleep. In general, people
More informationHow to Manage Insomnia with and without medications
How to Manage Insomnia with and without medications Tatyana Gurvich, Pharm.D. USC School of Pharmacy UC Irvine SeniorHealth Center Insomnia: How common is it? 26-50% of adult population complain of insomnia
More informationSLEEP-WAKE DISORDERS: INSOMNIA. Prof. Paz Gía-Portilla
SLEEP-WAKE DISORDERS: INSOMNIA Prof. Paz Gía-Portilla SLEEP-WAKE DISORDERS AND ICD-10 Chapter V: Mental and Behavioural Disorders F51. Non-organic sleep disorders Chapter VI: Nervous System Illnesses G47.
More informationChronic Insomnia: DSM - V. Insomnia DSM - V. Patient Symptoms. Insomnia: Assessment and Overview of Management. Insomnia Management in the Digital Age
Insomnia Management in the Digital Age Dr Anup Desai Sleep & Respiratory Medicine MBBS (syd), PhD (syd), FRACP Senior Staff Specialist, POW Hospital Medical Director, Sydney Sleep Centre Senior Lecturer,
More informationTreating Insomnia in Primary Care. Judith R. Davidson Ph.D., C. Psych. Kingston Family Health Team
Treating Insomnia in Primary Care Judith R. Davidson Ph.D., C. Psych. Kingston Family Health Team jdavidson@kfhn.net Disclosure statement Nothing to disclose A ruffled mind makes a restless pillow. ~ Charlotte
More informationADULT PRIMARY INSOMNIA
Clinical Practice Guideline Adult Primary Insomnia: Diagnosis to Management 2007 Update This guideline was developed by a Clinical Practice Guidelines Working Group to assist physicians in the management
More informationFaculty/Presenter Disclosure
A Little CBT I With My Tea Please: Cognitive Behavioural Therapy for insomnia (CBT I) and Its Use In the Treatment of Sleeplessness W. Jerome Alonso, MD Medical Director, Canadian Sleep Consultants Clinical
More informationInsomnia. F r e q u e n t l y A s k e d Q u e s t i o n s
Insomnia Q: What is insomnia? A: Insomnia is a common sleep disorder. If you have insomnia, you may: Lie awake for a long time and have trouble falling asleep Wake up a lot and have trouble returning to
More informationGuideline for Adult Insomnia
Guideline for Adult Insomnia Exclusions This guideline does not apply to: Children under the age of 18 Pregnant and lactating women Geriatric patients: While the general principles of the diagnosis and
More informationInsomnia. Dr Terri Henderson MBChB FCPsych
Insomnia Dr Terri Henderson MBChB FCPsych Plan Basics of insomnia Pharmacology Medication CBT Details of insomnia Unsatisfactory sleep that impairs daytime well-being Starts with specific problem or change
More informationRevolutionizing Cost Management... One Person at a Time.
Cypress Care, a leader in the workers compensation industry has expanded into the auto and Medicare Set-Aside markets by applying best practices and expertise - focused toward a single goal: Help our clients
More informationMichelle Zetoony, DO, FCCP, FACOI th Avenue S, Suite A Phone: Fax:
Michelle Zetoony, DO, FCCP, FACOI 545 4 th Avenue S, Suite A Phone: 727-826-0933 Fax: 727-826-0744 http://www.dosleep.com SLEEP TALK 9/9 BMJ Open2012 Pharmacology and therapeutics Research What is sleep?
More informationSleep Disorders: Assessment and Therapeutic Options
Sleep Disorders: Assessment and Therapeutic Options John W. Winkelman MD, PhD Chief, Sleep Disorders Clinical Research Program Departments of Psychiatry and Neurology Massachusetts General Hospital Professor
More informationSleep Science: better sleep for you and your patients CHUNBAI ZHANG, MD MPH UW MEDICINE VALLEY MEDICAL CENTER
Sleep Science: better sleep for you and your patients CHUNBAI ZHANG, MD MPH UW MEDICINE VALLEY MEDICAL CENTER Disclosure: Financial - none Non-Financial - none Selected Topics Sleep epidemiology Sleep
More informationOBJECTIVES. The psychiatric, medical, and neurologic causes of sleep problems. Office-based and objective methods of evaluating sleep
SLEEP ISSUES 1 OBJECTIVES 2 Know and understand: Age-related changes in sleep The psychiatric, medical, and neurologic causes of sleep problems Office-based and objective methods of evaluating sleep Appropriate
More informationPsychopharmacology of Sleep Disorders
Psychopharmacology of Sleep Disorders John W. Winkelman MD, PhD Chief, Sleep Disorders Clinical Research Program Departments of Psychiatry and Neurology Massachusetts General Hospital Professor of Psychiatry
More informationAvailable Strengths Limits. 200 mg tablets PA. 50 mg, 150 mg, 200 mg, 250 mg tablets. 500 mg/ml solution PA
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY Sleeping Disorders P&T DATE: 12/14/2016 THERAPEUTIC CLASS Psychiatric Disorders REVIEW HISTORY: 2/16, 5/15, 2/12 LOB AFFECTED
More informationModern Management of Sleep Disorders. If Only I Could Sleep Like I Did Before
Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures If Only I Could Sleep Like I Did Before Sleep Case 52 yr. old WF with >4 yr. of poor sleep
More information6/3/2015. Insomnia An Integrative Approach. Objectives. Why An Integrative Approach? Integrative Model. Definition. Short-term Insomnia
Insomnia An Integrative Approach Jeffrey S. Jump, M.D. Medical Director CHI Memorial Integrative Medicine Associates Objectives Understand the importance of sleep to health Identify patients with insomnia
More informationAmbien vs Rozerem There are people out there who have trouble falling asleep at night. Â Often, this would be considered as a disease that
22-10-2013 Ambien vs Rozerem There are people out there who have trouble falling asleep at night. Â Often, this would be considered as a disease that can be treated with Ambien vs Rozerem. Ambien:. Ramelteon
More informationACTIVITY DESCRIPTION Target Audience Learning Objectives
ACTIVITY DESCRIPTION Target Audience This activity is designed to meet the needs of primary care providers, including primary care physicians, doctors of osteopathy, physician assistants, nurse practitioners,
More informationInsomnia. St. Joseph s Annual Family Practice Refresher March 1, Robert J. Ostrander, M.D
St. Joseph s Annual Family Practice Refresher March 1, 2018 Robert J. Ostrander, M.D If in bed I say, When shall I arise? then the night drags on; I am filled with restlessness until the dawn. Job 7:4
More informationInsomnia Disorder A Journey to the Land of No Nod
Insomnia Disorder A Journey to the Land of No Nod JACQUELINE D. KLOSS, PH.D. P S Y C H O L O G I S T B R Y N M A W R P S Y C H O L O G I C A L A S S O C I A T E S B E H A V I O R A L S L E E P M E D I
More informationDRUGS THAT ACT IN THE CNS
DRUGS THAT ACT IN THE CNS Anxiolytic and Hypnotic Drugs Dr Karamallah S. Mahmood PhD Clinical Pharmacology 1 OTHER ANXIOLYTIC AGENTS/ A. Antidepressants Many antidepressants are effective in the treatment
More informationSEDATIVE-HYPNOTIC AGENTS
SEDATIVE-HYPNOTIC AGENTS Documentation A. FDA approved indications 1. Insomnia 2. Sedation for an agitated patient in an inpatient setting Documentation B. Non-FDA approved, commonly used indications 1.
More informationComparison of Insomnia Treatments
PL Detail-Document #280504 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER May 2012 Comparison of Insomnia
More informationSleep and Traumatic Brain Injury (TBI)
Sleep and Traumatic Brain Injury (TBI) A resource for individuals with traumatic brain injury and their supporters This presentation is based on TBI Model Systems research and was developed with support
More informationAnxiolytic and Hypnotic drugs
Anxiolytic and Hypnotic drugs Anxiolytic and Hypnotic drugs Anxiety is unpleasant state of tension and fear that seems to arise from unknown source. The symptoms of severe anxiety are similar to those
More informationCan you mix melatonin with lorazepam
Can you mix melatonin with lorazepam Drug interactions are reported among people who take Ativan and Melatonin together. This review analyzes the effectiveness and drug interactions between. Sleep Disorders:
More informationModern Management of Sleep Disorders. Case. Introduction. Topics Covered. Douglas C. Bauer, MD University of California, San Francisco
Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures Case 68 yr. old WF with >15 yr. of poor sleep Difficulty with both initiation and maintenance
More informationSleep and Parkinson's Disease
Parkinson s Disease Clinic and Research Center University of California, San Francisco 505 Parnassus Ave., Rm. 795-M, Box 0114 San Francisco, CA 94143-0114 (415) 476-9276 http://pdcenter.neurology.ucsf.edu
More informationInsomnia. Arturo Meade MD
Insomnia Arturo Meade MD Goals Definition Prevalence Pathophysiology The role of Orexin Orexin receptor blockers Consequences: Daily Functioning Insomnia: Consequences Decreased quality of life
More informationcontinuing education for pharmacists
continuing education for pharmacists General Insomnia Disorder in Adults and Treatment Guidelines Amanda R. Kriesen, R.Ph., PharmD Volume XXXV, No. 9 Dr. Amanda Kriesen has no relevant financial relationships
More informationMMG003 GUIDELINES FOR THE USE OF HYPNOTICS FOR THE TREATMENT OF INSOMNIA
MMG003 GUIDELINES FOR THE USE OF HYPNOTICS FOR THE TREATMENT OF INSOMNIA Page 1 of 11 Table of Contents Why we need this Guideline... 3 What the Policy is trying to do... 3 Which stakeholders have been
More informationSleeping Pills and Natural Sleep Aids
Sleeping Pills and Natural Sleep Aids Prescription and Over-the-Counter Products It s the middle of the night, and you re staring at the ceiling, thinking about work, or bills, or the kids. Sleep just
More informationINSOMNIA IN GERIATRICS. Presented By: Sara Kamalfar MD, Geriatrics Medicine Fellow
INSOMNIA IN GERIATRICS Presented By: Sara Kamalfar MD, Geriatrics Medicine Fellow Insomnia Insomnia is the inability to fall asleep, the inability to stay asleep, or waking up earlier than desired. To
More informationModern Management of Sleep Disorders
Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures Case 68 yr. old WF with >15 yr. of poor sleep Difficulty with both initiation and maintenance
More informationDrug Review Rozerem (ramelteon)
Drug Review Rozerem (ramelteon) Introduction 1 Ramelteon is a melatonin receptor agonist with affinity for MT 1 and MT 2 and selectivity over the MT 3 receptor. The activity at the MT 1 and MT 2 receptors
More informationThe Medical Letter. on Drugs and Therapeutics. Usual Adult Hypnotic Dose 1,2 Some Adverse Effects Comments Cost 3
The Medical Letter publications are protected by US and international copyright laws. Forwarding, copying or any other distribution of this material is strictly prohibited. For further information call:
More information일차진료에서불면증치료 김종우. Primary Insomnia : DSM-IV criteria 경희대학교의과대학정신과학교실 MEMO. Diagnostic Criteria for Insomnia (ICSD-2) 개원의와함께하는임상강좌
개원의와함께하는임상강좌 2011 일차진료에서불면증치료 경희대학교의과대학정신과학교실 김종우 Diagnostic Criteria for Insomnia (ICSD-2) International Classification of Sleep Disorders, 2nd Edition (ICSD-2) Primary Insomnia : DSM-IV criteria A. The
More informationWhat is sleep? o Sleep is a body s rest cycle.
What is sleep? o Sleep is a state when our senses and motor actvity are relatively suspended; there is a total or partial unconsciousness and all voluntary muscles are inactive. o Sleep is a body s rest
More informationBeyond Sleep Hygiene: Behavioral Approaches to Insomnia
Beyond Sleep Hygiene: Behavioral Approaches to Insomnia Rocky Garrison, PhD, CBSM Damon Michael Williams, RN, PMHNP-BC In House Counseling Laughing Heart LLC 10201 SE Main St. 12 SE 14 th Ave. Suite 10
More informationObjectives. Types of Sleep Problems in Developmental Disorders
Objectives Sleep Problems in the Child with Neurodevelopmental Disorders AACPDM September 11, 2014 BRK-3 Golda Milo-Manson MD, MHSc, FRCP(C) Holland Bloorview Kids Rehabilitation Hospital Toronto, Canada
More informationRECIPES FOR A GOOD NIGHT S SLEEP
RECIPES FOR A GOOD NIGHT S SLEEP Maribeth Gallagher, PMHNP-BC, MS Hospice of the Valley Objectives: Describe the most common changes in sleep that occur in older adults. Discuss the possible negative effects
More informationSleep and Insomnia 2/8/2018. Presented by. Marie Rataj, MSN, APRN, ANP. Objectives. Everything you wanted to know
Sleep and Insomnia Everything you wanted to know Presented by Marie Rataj, MSN, APRN, ANP Objectives Develop a basic knowledge of normal sleep and differentiate from abnormal sleep Develop basic understanding
More informationSeminar. Chronic insomnia
Chronic insomnia Charles M Morin, Ruth Benca Insomnia is a prevalent complaint in clinical practice that can present independently or comorbidly with another medical or psychiatric disorder. In either
More informationCognitive Behavioral Therapy for Insomnia. Melanie K. Leggett, PhD, CBSM Duke University Medical Center
Cognitive Behavioral Therapy for Insomnia Melanie K. Leggett, PhD, CBSM Duke University Medical Center Disclosures I have no relevant financial relationship with the manufacturers of any commercial products
More informationPRACTICAL MANAGEMENT OF INSOMNIA IN THE OFFICE
PRACTICAL MANAGEMENT OF INSOMNIA IN THE OFFICE NORAH VINCENT, PHD., C. PSYCH. PSYCHOLOGIST, WINNIPEG REGIONAL HEALTH AUTHORITY PROFESSOR, DEPARTMENT OF CLINICAL HEALTH PSYCHOLOGY, UNIVERSITY OF MANITOBA
More informationKatee Kindler, PharmD, BCACP
Speaker Introduction Katee Kindler, PharmD, BCACP Current Practice: Clinical Pharmacy Specialist Ambulatory Care, St. Vincent Indianapolis Assistant Professor of Pharmacy Practice, Manchester University,
More informationSLEEP UPDATE 2008 SLEEP HYPNOGRAM. David Claman, MD UCSF Sleep Disorders Center
SLEEP UPDATE 2008 SLEEP HYPNOGRAM David Claman, MD UCSF Sleep Disorders Center Insomnia Case A 40 year old man c/o insomnia at sleep onset. He worries about sleep at night, and takes 2-3 hrs to fall asleep.
More informationA Review of Sleep Disorders in Cancer Patients: Finding the Dream Treatment
A Review of Sleep Disorders in Cancer Patients: Finding the Dream Treatment Jordan Pleskow, PharmD Roswell Park Cancer Institute Oncology Symposium 11/11/17 Objectives Evaluate the issues with sleep in
More informationOutline. Disclosure. Sleep and the Elderly 1,2. Background
Geriatric Grand Rounds Tuesday, March 31, 29 12: noon Dr. Bill Black Auditorium Glenrose Rehabilitation Hospital In keeping with Glenrose Rehabilitation Hospital policy, speakers participating in this
More informationObjectives. Disclosure. APNA 26th Annual Conference Session 2017: November 8, Kurtz 1. The speaker has no conflicts of interest to disclose
Christine Kurtz, DNP, PMHCNS BC Valparaiso University Disclosure The speaker has no conflicts of interest to disclose Objectives The learner will Describe the rationale for and five therapies of CBT I
More informationCognitive-Behavioral Therapy for Insomnia
Wisconsin Department of Health Services Wisconsin Public Psychiatry Network Teleconference (WPPNT) This teleconference is brought to you by the Wisconsin Department of Health Services (DHS) Bureau of Prevention,
More informationYou May Be at Risk. You are currently taking a sedative-hypnotic drug. Please Bring This Information With You To Your Next Medical Appointment
You are currently taking a sedative-hypnotic drug Alprazolam Chlordiazepoxide Clonazepam Diazepam Estazolam Flurazepam Lorazepam Oxazepam Temazepam Triazolam Eszopiclone Zaleplon Zolpidem Please Bring
More informationDrug Class Update: Sedatives
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationSleep Disorders in the Psychiatric Context
Sleep Disorders in the Psychiatric Context John W. Winkelman MD, PhD Chief, Sleep Disorders Clinical Research Program Departments of Psychiatry and Neurology Massachusetts General Hospital Associate Professor
More informationFacts about Sleep. Circadian rhythms are important in determining human sleep patterns/ sleep-waking cycle
Sleep Sleep is described as a state of unconsciousness or partial consciousness from which a person can be roused by stimulation Period of rest and recovery People spend about a third of their lives sleeping
More informationInsomnia Pearls in the Geriatric Population
Insomnia Pearls in the Geriatric Population September 9, 2016 Stephanie Loegering, PharmD, CGP Clinical Pharmacist VA Medical Center Thank You MPhA Wi-fi Information: NETWORK: EC-CTR PASSWORD: westgate252
More informationMany people with physical
FACTSHEET How to Sleep Better Many people with physical disabilities suffer from sleep disturbances, and sleep tends to become more disrupted as we get older. Not sleeping well can negatively impact your
More informationUtilizing Cognitive-Behavioral Therapy for Insomnia to Facilitate Discontinuation of Sleep Medication in Chronic Insomnia Patients
Pharmacological Treatment of Insomnia: Hypnotic Medication Historically, pharmacotherapy has been the first line treatment for insomnia and remains a popular choice of treatment. 8,9 Approximately 3 to
More informationAnxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Anxiolytic, Sedative and Hypnotic Drugs Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Anxiolytics: reduce anxiety Sedatives: decrease activity, calming
More informationDisclosures. Speaker: Teva, UCB, Purdue Advisory Board: Welltrinsic Sleep Network Consultant: Vapotherm, Inc. National Interpretor: Novasom
So PAP Doesn t Work Rochelle Goldberg, MD, FAASM, FCCP Diplomat, American Board of Sleep Medicine Director Sleep Medicine Services Main Line Health Systems Lankenau Medical Center and Paoli Hospital Disclosures
More informationInsomnia: habits, help, and hazards
Insomnia: habits, help, and hazards Balanced data about medications www.rxfacts.org Copyright 2010 by The Alosa Foundation www.rxfacts.org November 2010 2 www.rxfacts.org Author: Leslie Jackowski, B.Sc.,
More informationINTRINSIC SLEEP DISORDERS. Excessive daytime sleepiness (EDS) is a common complaint. Causes of EDS are numerous and include:
INTRINSIC SLEEP DISORDERS Introduction Excessive daytime sleepiness (EDS) is a common complaint. Causes of EDS are numerous and include: Intrinsic sleep disorders (e.g. narcolepsy, obstructive sleep apnoea/hypopnea
More information3/24/2016 DISCLOSURE STATEMENT PHARMACIST OBJECTIVES OVERVIEW TECHNICIAN OBJECTIVES PREVALENCE OF INSOMNIA THE WRONG SIDE OF THE BED: CHRONIC INSOMNIA
DISCLOSURE STATEMENT I do not have any actual or potential conflict of interest in relation to this presentation THE WRONG SIDE OF THE BED: CHRONIC INSOMNIA DANIELLE ROWAN, PHARMD, MBA PGY1 PHARMACY PRACTICE
More informationIndividual Planning: A Treatment Plan Overview for Individuals Sleep Disorder Problems.
COURSES ARTICLE - THERAPYTOOLS.US Individual Planning: A Treatment Plan Overview for Individuals Sleep Disorder Problems. Individual Planning: A Treatment Plan Overview for Individuals Sleep Disorder Problems.
More informationTreatment of Insomnia for Clinicians
Treatment of Insomnia for Clinicians Larry Pawluk, M.D., FRCPC Diplomate, American Board of Sleep Medicine Clinical Professor of Psychiatry, Sleep Medicine Program, University of Alberta What is Insomnia?
More informationCOMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK
COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company) 2 3 4 5 Pharmacogenomics
More informationMCCN Supra-Regional Audit of Insomnia Management in Palliative Care
MCCN Supra-Regional Audit of Insomnia Management in Palliative Care Barbara Humphries Caroline Irvine Andrew Khodabukus Richard Latten Jenny Smith Phil Swarbrick Carolyn Watt - Countess of Chester Hospital
More informationImproving Sleep: Promoting Sleep Hygiene Techniques
University of Vermont ScholarWorks @ UVM Family Medicine Clerkship Student Projects College of Medicine 2018 Improving Sleep: Promoting Sleep Hygiene Techniques Katherine Clifford University of Vermont
More informationGeriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center
Geriatric Pharmacology Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Silver Tsunami 2010: 40 million (13%) 2030: 72 million (20%) Baby Boomers (1946-1964)
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abuse sleep physiology effects of, 880 882 substance, in adolescents, sleep problems and, 929 946. See also Substance use and abuse, in adolescents,
More informationHetlioz (tasimelteon)
Hetlioz (tasimelteon) Policy Number: 5.01.687 Last Review: 01/2019 Origination: 01/2019 Next Review: 01/2020 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for Hetlioz
More information노인병원에서 Light Therapy 의 활용 박 기 형 진주삼성병원 송도병원 신경과
Light Therapy 1 : 15 / 63 (23.8%) 1 : 7 2 : 8 : 6 / 86 (7%) 1, : 48 / 205 (23.4%) 1 : 43 2 : 5 Sleep in Geriatrics Prevalence NIH survey of 9000 american senior above age 65 ; 88% had sleep disturbances
More information